Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Private Placement	Common Stock	Common Stock Private Placement	Additional Paid-In Capital	Additional Paid-In Capital Private Placement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 211,539		$ 41		$ 514,362		$ (397)	$ (302,467)
Beginning balance, Shares at Dec. 31, 2021			40,626,224
Issuance of common stock under employee benefit plans	395				395
Issuance of common stock under employee benefit plans, Shares			47,627
Vesting of restricted stock awards, Shares			9,754
Stock-based compensation expense	3,847				3,847
Unrealized (loss) gain on marketable securities	(693)						(693)
Net loss	(25,928)							(25,928)
Ending balance at Mar. 31, 2022	189,160		$ 41		518,604		(1,090)	(328,395)
Ending balance, Shares at Mar. 31, 2022			40,683,605
Beginning balance at Dec. 31, 2021	211,539		$ 41		514,362		(397)	(302,467)
Beginning balance, Shares at Dec. 31, 2021			40,626,224
Unrealized (loss) gain on marketable securities	(671)
Net loss	(59,998)
Ending balance at Jun. 30, 2022	160,755		$ 41		524,247		(1,068)	(362,465)
Ending balance, Shares at Jun. 30, 2022			41,008,205
Beginning balance at Dec. 31, 2021	211,539		$ 41		514,362		(397)	(302,467)
Beginning balance, Shares at Dec. 31, 2021			40,626,224
Ending balance at Dec. 31, 2022	198,942		$ 52		612,025		(797)	(412,338)
Ending balance, Shares at Dec. 31, 2022			52,099,211
Beginning balance at Mar. 31, 2022	189,160		$ 41		518,604		(1,090)	(328,395)
Beginning balance, Shares at Mar. 31, 2022			40,683,605
Issuance of common stock under employee benefit plans	2,764				2,764
Issuance of common stock under employee benefit plans, Shares			324,180
Vesting of restricted stock awards, Shares			420
Stock-based compensation expense	2,879				2,879
Unrealized (loss) gain on marketable securities	22						22
Net loss	(34,070)							(34,070)
Ending balance at Jun. 30, 2022	160,755		$ 41		524,247		(1,068)	(362,465)
Ending balance, Shares at Jun. 30, 2022			41,008,205
Beginning balance at Dec. 31, 2022	198,942		$ 52		612,025		(797)	(412,338)
Beginning balance, Shares at Dec. 31, 2022			52,099,211
Issuance of common stock in connection with public offering, net of issuance costs		$ 117,346		$ 10		$ 117,336
Issuance of common stock in connection with public offering, net of issuance costs, Shares				9,615,384
Issuance of common stock under employee benefit plans	348				348
Issuance of common stock under employee benefit plans, Shares			38,903
Vesting of restricted stock awards, Shares			5,496
Stock-based compensation expense	4,253				4,253
Unrealized (loss) gain on marketable securities	146						146
Net loss	(24,779)							(24,779)
Ending balance at Mar. 31, 2023	296,256		$ 62		733,962		(651)	(437,117)
Ending balance, Shares at Mar. 31, 2023			61,758,994
Beginning balance at Dec. 31, 2022	198,942		$ 52		612,025		(797)	(412,338)
Beginning balance, Shares at Dec. 31, 2022			52,099,211
Unrealized (loss) gain on marketable securities	(403)
Net loss	(48,562)
Ending balance at Jun. 30, 2023	275,428		$ 62		737,466		(1,200)	(460,900)
Ending balance, Shares at Jun. 30, 2023			61,822,554
Beginning balance at Mar. 31, 2023	296,256		$ 62		733,962		(651)	(437,117)
Beginning balance, Shares at Mar. 31, 2023			61,758,994
Issuance of common stock under employee benefit plans	141				141
Issuance of common stock under employee benefit plans, Shares			50,912
Vesting of restricted stock awards, Shares			12,648
Stock-based compensation expense	3,363				3,363
Unrealized (loss) gain on marketable securities	(549)						(549)
Net loss	(23,783)							(23,783)
Ending balance at Jun. 30, 2023	$ 275,428		$ 62		$ 737,466		$ (1,200)	$ (460,900)
Ending balance, Shares at Jun. 30, 2023			61,822,554